The Israel-U.S. Foundation is investing $9.6 million in 10 new projects jointly implemented by Israeli and American companies in the fields of agritech, biotechnology, electronics, energy, foodtech, healthcare, and life sciences. .
The BIRD Foundation (Binational Industrial Research and Development) encourages cooperation between U.S. and Israeli companies in various technology fields.
The Foundation will provide grants of up to $1.5 million to each project, as well as help identify and facilitate introductions to potential strategic partners.
In addition to funding from BIRD, each project will receive funding from the private sector, increasing the total investment to $24.5 million.
The projects are:
Celleste Bio (Misgav) and Mondelez International (Chicago, IL) will develop on-demand fat-free cocoa solids and powders using cell-based technology.
CENS Materials (Beer Sheva) and LiCAP Technologies (Sacramento, Calif.) will develop processes to increase battery capacity and performance in electric vehicles.
Diptera.ai (Jerusalem) and Vectech (Baltimore, Maryland) use AI to monitor and control mosquitoes known as Anopheles, which are highly effective at transmitting malaria.
Opmed.AI (formerly Greatnix (Herzliya)) and Mayo Clinic (Rochester, Minn.) are launching an AI-driven technology aimed at optimizing surgical schedules, increasing operating room efficiency, and maximizing resource utilization. Develop a planner.
Hypervision (Yokneam Illit) and Light Polymers (Santa Clara, California) will develop liquid crystal-based polarizing coating technology for virtual reality and mixed reality optics.
ImaginDairy (Haifa) and Ginkgo Bioworks (Boston, MA) develop and manufacture non-whey dairy proteins.
Israel Aerospace Industries (Lod) and MELD Printworks (Christianburg, Virginia) will develop large civil aviation parts using layered friction stir deposition technology, a manufacturing technique that can be used to fabricate metals.
LahakX (Ramat Hasharon) and Aero Systems West (San Martin, California) will develop heavy-lift application drones for agriculture and fire protection.
Sheba Medical Center (Ramat Gan) and Serpin Pharma (Manassas, VA) will conduct a Phase II clinical trial to prove a targeted therapy that restores immune balance in patients with acute myocardial infarction.
Tissue Dynamics (Rehovot) and ATCC (Manassas, VA) will develop an advanced organoid kit for cardiotoxicity assessment.
“At BIRD, we are extremely proud to have awarded grants to a record number of projects that emphasize innovation to deliver commercial products and strengthen U.S.-Israel cooperation,” said BIRD Executive Director Jaron Lotan said.
“During this cycle, we witnessed a diverse range of projects across sectors and geographies, demonstrating our commitment to fostering impactful partnerships and fostering innovation across diverse areas. ”
